Systematic Analysis of Molecular Mechanisms of Exercise in Regulating Cholesterol Biosynthesis: Molecular Network Modeling for Therapeutic Target Identification

Document Type : Research Paper

Authors
1 Department of Exercise Physiology, Faculty of Sport Sciences, University of Isfahan, Isfahan, Iran
2 Department of Genetics, Royan Institute of Biotechnology, Isfahan, Iran
Abstract
Extended Abstract
Background and Purpose
This study investigates the intricate regulation of cholesterol biosynthesis, a vital metabolic process governed by a network of genes central to cholesterol synthesis, lipid metabolism, and cellular signaling. Focusing on four key genes—Idi1, Fdps, Sqle, and Hmgcs1—it examines their regulatory mechanisms under different physiological and environmental conditions, including high-fat dietary intake and physical exercise. Using computational modeling, the research deciphers complex interactions within these gene regulatory networks, aiming to provide a systems-level understanding of cholesterol biosynthesis regulation. In parallel, it explores innovative therapeutic targets, particularly microRNAs, as strategies for managing dyslipidemia. By integrating systems biology methodologies with bioinformatics tools, the study not only deepens understanding of cholesterol metabolism but also evaluates the potential impacts of exercise interventions and novel pharmaceutical approaches on lipid disorders. Ultimately, it seeks to identify critical pathways and molecular targets to inform the development of effective therapeutic strategies.
Materials and Methods
A computational systems biology design was employed to elucidate the regulatory mechanisms that coordinate cholesterol biosynthesis under different conditions, such as high-fat diet consumption and physical exercise. The analysis concentrated on the regulatory roles of Idi1, Fdps, Sqle, and Hmgcs1—genes known to play essential roles in lipid metabolism and cellular signaling.
Gene regulatory network construction and analysis were performed using advanced bioinformatics pipelines and computational modeling techniques. Transcriptional data provided the basis for mapping gene–gene interactions, permitting detailed characterization of their roles within the dynamic regulation of cholesterol biosynthetic pathways. Simulations of regulatory network behavior under diverse conditions, including high-fat diet exposure, were conducted to examine their impact on gene expression profiles and pathway dynamics.
To ensure biological relevance, network topology clustering analyses were validated through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Further, the study evaluated how high-fat dietary intake and physical activity modulate these networks, with particular emphasis on mechanisms that restore lipid metabolic homeostasis.
As part of the therapeutic exploration, potential microRNA regulators targeting network nodes were identified. These computational predictions, integrated with available experimental findings, refined the regulatory models and allowed identification of key nodes, hubs, and interactions that represent promising intervention points for dyslipidemia management.
Results
Analysis of transcriptional activity confirmed that Idi1, Fdps, Sqle, and Hmgcs1 act as prominent hub genes in cholesterol biosynthesis, lipid metabolism, and broader cellular signaling. The regulatory network analysis revealed these genes as central mediators in controlling metabolic flux within cholesterol biosynthetic pathways.
Clustering analysis of the networks, supported by GO and KEGG enrichment, validated the biological coherence and functional significance of these pathways. These results highlighted essential interactions and core modules critical for maintaining cholesterol homeostasis, particularly in the face of environmental stressors such as high-fat diets.
Computational simulations demonstrated that exposure to a high-fat diet markedly alters the expression patterns of the key regulatory genes, disrupting network stability. In contrast, physical exercise interventions produced a counterbalancing effect, modulating the expression of hub genes toward restoring lipid metabolic balance. The model thus provided clear evidence for the potential of targeted exercise regimes to mitigate diet-induced dysregulation of cholesterol metabolism.
A further significant outcome was the identification of multiple microRNAs with regulatory influence over cholesterol biosynthesis networks. These microRNAs appear to modulate hub gene activity, presenting themselves as novel and potentially powerful therapeutic targets for dyslipidemia and associated metabolic disorders.
Integration of experimental datasets with computational models yielded an enriched systems-level perspective on gene–gene and gene–microRNA interactions. This integration enabled the pinpointing of pivotal regulatory nodes and feedback mechanisms that could be exploited for future diagnostic and therapeutic innovations.
Conclusion
This study offers comprehensive insights into the regulation of cholesterol biosynthesis, detailing the roles of the hub genes Idi1, Fdps, Sqle, and Hmgcs1. Through computational modeling supported by transcriptional profiles, it demonstrates dynamic regulation of these pathways under high-fat diet and exercise conditions, emphasizing the modulatory benefits of physical activity in maintaining lipid homeostasis.
Importantly, the research identifies regulatory microRNAs as promising therapeutic targets, heralding new approaches for managing dyslipidemia and related cardiovascular-metabolic disorders. By integrating bioinformatics and systems biology frameworks, it systematically maps the critical pathways and molecular interactions underlying cholesterol metabolism. The findings not only advance mechanistic understanding but also offer a robust foundation for designing targeted interventions—be they exercise prescriptions, microRNA-based therapeutics, or novel pharmacological agents—to optimize cholesterol regulation and improve metabolic health outcomes.
Keywords: Cholesterol Biosynthesis, Gene Regulatory Networks, Dyslipidemia, Exercise, Bioinformatics
Article Message
By identifying and characterizing key hub genes in cholesterol biosynthesis and elucidating their connections within gene regulatory networks, this study advances the understanding of cholesterol metabolism and the involvement of the cellular endoplasmic reticulum. GO and KEGG analyses confirm the inclusion of these genes in critical metabolic processes, suggesting their value as diagnostic biomarkers for metabolic diseases. The demonstrated interplay between physical activity and cholesterol biosynthesis underscores its potential as an effective strategy for metabolic regulation, with therapeutic implications spanning exercise-based interventions to targeted molecular therapies.
Ethical Considerations
This research was approved by the Ethics Committee of the University of Isfahan (Ethical Code: IR.UI.REC.1403.005).
Authors’ Contributions
Conceptualization, Data Collection, Manuscript Writing: Milad Abdollahi
Project Management, Review and Editing: Sayyed Mohammad Marandi
Data Analysis, Review and Editing: Zahra Safayinejad
Literature Review, Review and Editing: Mohammad Hossein Nasr Esfahani
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
The authors express deep appreciation to the Institute of Physical Education and Sport Sciences for their consistent and invaluable support throughout the course of this research.
Keywords

Main Subjects


1.     Wang L, Duan W, Ruan C, Liu J, Miyagishi M, Kasim V, Wu S. YY2-CYP51A1 signaling suppresses hepatocellular carcinoma progression by restraining de novo cholesterol biosynthesis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2025;(3):31871. https://doi.org/10.1016/j.bbadis.2025.167658و
2.     Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell. 2015;161(1):161-72. https://doi.org/ 10.1016/j.cell.2015.01.036 (Cell / PubMed).
3.     Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Medicine. 2014;44:211-21. https://doi.org/ 10.1007/s40279-013-0110-5 (PubMed).
4.     Noubiap JJN, Nansseu JRN, Bigna JJR, Jingi AM, Kengne AP. Prevalence and incidence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis protocol. BMJ Open. 2015;5(3):e007404. https://doi.org/ 10.1136/bmjopen-2014-007404 (BMJ Open).
5.     Timori M, Ajami M, Shakerian M, Sareh M, Abdollahi M. Assessment of non-communicable diseases status and dietary patterns in patients with dyslipidemia in Alvand city. Iranian Journal of Epidemiology. 2024;20(2):106-17. https://doi.org/ 10.18502/ijre.v20i2.17634.
6.     Brooks GA, Fahey TD, Baldwin KM. Exercise physiology: human bioenergetics and its applications. 2005. https://doi.org/ ISBN-13: 9780072556421.
7.     Liu C, Chen H, Hu B, Shi J, Chen Y, Huang K. New insights into the therapeutic potentials of statins in cancer. Frontiers in Pharmacology. 2023;14:118892. https://doi.org/ 10.3389/fphar.2023.1124596 (Frontiers)
8.     Kenney WL, Wilmore JH, Costill DL. Physiology of sport and exercise: Human Kinetics; 2022. https://doi.org/ISBN-13: 9781718203676
9.     Smart NA, Downes D, Van Der Touw T, Hada S, Dieberg G, Pearson MJ, et al. The effect of exercise training on blood lipids: a systematic review and meta-analysis. Sports Medicine. 2024:1-12. https://doi.org/10.1007/s40279-017-0816-5
10. Long T, Debler EW, Li X. Structural enzymology of cholesterol biosynthesis and storage. Current Opinion in Structural Biology. 2022;74:102369. https://doi.org/ 10.1016/j.sbi.2022.102369.
11. Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduction and Targeted Therapy. 2022;7(1):265. https://doi.org/10.1038/s41392-022-01125-5.
12. Shi Q, Chen J, Zou X, Tang X. Intracellular cholesterol synthesis and transport. Frontiers in Cell and Developmental Biology. 2022;10:819281. https://doi.org/ 10.3389/fcell.2022.819281.
13. Xie H, Weinstein H. Recognition of specific pip2-subtype composition triggers the allosteric control mechanism for selective membrane targeting of cargo loading and release functions of the intracellular sterol transporter stard4. J Mol Bio. 2025;169157. http://dx.doi.org/10.2139/ssrn.5071483
14. Kumar R, Chhillar N, Gupta DS, Kaur G, Singhal S, Chauhan T. Cholesterol homeostasis, mechanisms of molecular pathways, and cardiac health: a current outlook. Current Problems in Cardiology. 2024;49(1):102081. https://doi.org/ 10.1016/j.cpcardiol.2023.102081 (ScienceDirect).
15. Li M, Li D, Tang Y, Wu F, Wang J. CytoCluster: a cytoscape plugin for cluster analysis and visualization of biological networks. International Journal of Molecular Sciences. 2017;18(9):1880. https://doi.org/10.3390/ijms18091880
16. Ma Y, Kan C, Qiu H, Liu Y, Hou N, Han F, et al. Transcriptomic analysis reveals the protective effects of empagliflozin on lipid metabolism in nonalcoholic fatty liver disease. Frontiers in Pharmacology. 2021;12:793586. https://doi.org/ 10.3389/fphar.2021.793826 (Frontiers).
17. Arivazhagan L, Delbare S, Wilson RA, Manigrasso MB, Zhou B, Ruiz HH, et al. Sex differences in murine MASH induced by a fructose-palmitate-cholesterol-enriched diet. JHEP Reports. 2025;7(2):101222. https://doi.org/ 10.1016/j.jhepr.2024.101222.
18. Wang W, Chen Y, Bai L, Zhao S, Wang R, Liu B, et al. Transcriptomic analysis of the liver of cholesterol-fed rabbits reveals altered hepatic lipid metabolism and inflammatory response. Scientific Reports. 2018;8(1):6437. https://doi.org/ 10.1038/s41598-018-24813-1.
19. Cheng CW, Pedicini L, Alcala CM, Deligianni F, Smith J, Murray RD, et al. RNA-seq analysis reveals transcriptome changes in livers from Efcab4b knockout mice. Biochemistry and Biophysics Reports. 2025;41:101944. https://doi.org/10.1016/j.bbrep.2025.101944
20. Melo L, Hagar A, Klaunig J. Gene expression signature of exercise and change of diet on non-alcoholic fatty liver disease in mice. Comparative Exercise Physiology. 2022;18(2):143-54. https://doi.org/10.3920/CEP210033
21. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431-2. https://doi.org/10.1093/bioinformatics/btq675
22. Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Systems Biology. 2014;8:1-7. https://doi.org/10.1186/1752-0509-8-S4-S11
23. Yon Rhee S, Wood V, Dolinski K, Draghici S. Use and misuse of the gene ontology annotations. Nature Reviews Genetics. 2008;9(7):509-15. https://doi.org/10.1038/nrg2363
24. Aguilera-Olguín M, Leiva A. The LDL receptor: Traffic and function in trophoblast cells under normal and pathological conditions. Placenta. 2022;127:12-9. https://doi.org/ 10.1016/j.placenta.2022.07.013.
25. Zhou F, Sun X. Cholesterol metabolism: a double-edged sword in hepatocellular carcinoma. Frontiers in Cell and Developmental Biology. 2021;9:762828. https://doi.org/10.3389/fcell.2021.707733 (Frontiers).
26. Zhao Z, Li B, Chen Q, Xiang X, Xu X, Han S, et al. Dietary palm oil enhances Sterol regulatory element-binding protein 2-mediated cholesterol biosynthesis through inducing endoplasmic reticulum stress in muscle of large yellow croaker (Larimichthys crocea). British Journal of Nutrition. 2024;131(4):553-66. https://doi.org/10.1017/S0007114523001344.
27. Xia Q, Lu F, Chen Y, Li J, Huang Z, Fang K, et al. 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway. Biomedicine & Pharmacotherapy. 2024;170:116060. https://doi.org/10.1016/j.biopha.2023.116060
28. Dao W, Chen H, Ouyang Y, Huang L, Fan X, Miao Y. Molecular characteristics and role of buffalo SREBF2 in triglyceride and cholesterol biosynthesis in mammary epithelial cells. Genes. 2025;16(2):237. https://doi.org/10.3390/genes16020237
29. Ribas V. Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat. Exploration of Digestive Diseases. 2024;3(3):203-25. https://doi.org/ 10.37349/edd.2024.00048.
30. Xu H, Li Y, Guo N, Wu S, Liu C, Gui Z, et al. Caveolin-1 mitigates the advancement of metabolic dysfunction-associated steatotic liver disease by reducing endoplasmic reticulum stress and pyroptosis through the restoration of cholesterol homeostasis. International Journal of Biological Sciences. 2025;21(2):490. https://doi.org/ 10.7150/ijbs.100794.
31. Zhang C, Dai W, Yang S, Wu S, Kong J. Resistance to cholesterol gallstone disease: hepatic cholesterol metabolism. The Journal of Clinical Endocrinology & Metabolism. 2024;109(4):912-23. https://doi.org/10.1210/clinem/dgad528
32. Jang W, Haucke V. ER remodeling via lipid metabolism. Trends in Cell Biology. 2024. https://doi.org/10.1016/j.tcb.2024.01.011 
33. Knoblach B, Rachubinski RA. Peroxisome population control by phosphoinositide signaling at the endoplasmic reticulum‐plasma membrane interface. Traffic. 2024;25(1):e12923. https://doi.org/10.1111/tra.12923
34.    Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research. 2000;28(1):27-30. https://doi.org/ 10.1093/nar/28.1.27.
35. Waterham HR, Vaz FM. Cholesterol Biosynthesis Metabolites. Laboratory Guide to the Methods in Biochemical Genetics: Springer; 2024. p. 267-82. https://doi.org/ 10.1007/978-3-031-58819-8_15
36. Zhang X, Chen Y, Sun G, Fei Y, Zhu H, Liu Y, et al. Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling. Nature Metabolism. 2024:1-20. https://doi.org/10.1038/s42255-024-01149-x
37. Chen M, Yang Y, Chen S, He Z, Du L. Targeting squalene epoxidase in the treatment of metabolic-related diseases: current research and future directions. PeerJ. 2024;12:e18522. https://doi.org/10.7717/peerj.18522
38. Picón DF, Skouta R. Unveiling the therapeutic potential of squalene synthase: deciphering its biochemical mechanism, disease implications, and intriguing ties to ferroptosis. Cancers. 2023;15(14):3731. https://doi.org/10.3390/cancers15143731
39. Kakiyama G, Rodriguez-Agudo D, Pandak WM. Mitochondrial cholesterol metabolites in a bile acid synthetic pathway drive nonalcoholic fatty liver disease: a revised “two-hit” hypothesis. Cells. 2023;12(10):1434. https://doi.org/10.3390/cells12101434.
40. Russo-Savage L, Schulman IG. Liver X receptors and liver physiology. Biochimica et Biophysica Acta Molecular Basis of Disease. 2021;1867(6):166121. https://doi.org/ j.bbadis.2021.166121/10.1016
41. Kennewick KT, Bensinger SJ. Decoding the crosstalk between mevalonate metabolism and T cell function. Immunological Reviews. 2023;317(1):71-94. https://doi.org/ DOI: 10.1111/imr.13200
42. Liu J, Zhang X, Zhang Y, Qian M, Yang M, Yang S, Wang L. Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR‐CD36 axis. The FASEB Journal. 2023;37(7):e23035. https://doi.org/ fj.202300590RR/10.1096
43. Liebl M, Olander F, Müller C. Targeting the isoprenoid pathway in choleste biosynthesis: An approach to identify isoprenoid biosynthesis inhibitors. Archiv der Pharmazie. 2025;358(2):e2400807. https://doi.org/10.1002/ardp.202400807.
44. Li X, Li M. Unlocking cholesterol metabolism in metabolic-associated steatotic liver disease: molecular targets and natural product interventions. Pharmaceuticals. 2024;17(8):1073. https://doi.org/10.3390/ph17081073.
45. Kamel EM, Othman SI, Alkhayl FFA, Rudayni HA, Allam AA, Lamsabhi AM. Mechanistic insights into alkaloid-based inhibition of squalene epoxidase: a combined in silico and experimental approach for targeting cholesterol biosynthesis. International Journal of Biological Macromolecules. 2025:140609. https://doi.org/10.1016/j.ijbiomac.2025.140609.
46. Spaulding HR, Yan Z. AMPK and the adaptation to exercise. Annual Review of Physiology. 2022;84(1):209-27. https://doi.org/ 10.1146/annurev-physiol-060721-095517
47. Richter EA, Ruderman NB. AMPK and the biochemistry of exercise: implications for human health and disease. Biochemical Journal. 2009;418(2):261-75. https://doi.org/ 10.1042/BJ20082055
48. Lee TV. Dietary Cholesterol and Resistance Training as Countermeasures to Accelerated Muscle Loss 2015. https://doi.org/10.1101/2024.10.21.619494
49. Maleki S, Azarbayjani MA, Riyahi MS, Peeri M, Rahmati AS. The effect of aerobic exercise and ethanolic extract of rice bran on the expression of Acetyl-CoA Carboxylase and HMGCR genes in the liver tissue of rats fed with a high-fat diet. Health. 2024;2(3):89-100. https://doi.org/ 10.61838/kman.hn.2.3.11
50. Kahl CG, Deas C. Exercise-induced anaphylaxis in an air force aviator taking a HMG-CoA reductase inhibitor: a case report and review of the presentation, diagnoses, and treatment. Military Medicine. 2017;182(5-6):e1816-e9. https://doi.org/10.7205/MILMED-D-16-00247.
51. Kugler BA, Maurer A, Fu X, Franczak E, Ernst N, Schwartze K, et al. Aerobic capacity and exercise mediate protection against hepatic steatosis via enhanced bile acid metabolism. bioRxiv. 2024. https://doi.org/ 10.1101/2024.10.21.619494
52. Berglund I, Vesterbekkmo EK, Retterstøl K, Anderssen SA, Singh MAF, Helge JW, et al. The long-term effect of different exercise intensities on high-density lipoprotein cholesterol in older men and women using the per protocol approach: the Generation 100 Study. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2021;5(5):859-71. https://doi.org/ 10.1016/j.mayocpiqo.2021.07.002
53. Zhang L, Cao Z, Hong Y, He H, Chen L, Yu Z, Gao Y. Squalene epoxidase: its regulations and links with cancers. International Journal of Molecular Sciences. 2024;25(7):3874. https://doi.org/ 10.3390/ijms25073874
54. Liu J, Liu W, Wan Y, Mao W. Crosstalk between exercise and immunotherapy: current understanding and future directions. Research. 2024;7:0360. https://doi.org/10.34133/research.0360
55. Fan X, Wang H, Wang W, Shen J, Wang Z. Exercise training alleviates cholesterol and lipid accumulation in mice with non-alcoholic steatohepatitis: Reduction of KMT2D-mediated histone methylation of IDI1. Experimental Cell Research. 2024;442(2):114265. https://doi.org/10.1016/j.yexcr.2024.114265
Volume 17, Issue 65
March 2025
Pages 96-72

  • Receive Date 23 March 2025
  • Revise Date 22 June 2025
  • Accept Date 04 July 2025